1. Home
  2. BCAL vs SLDB Comparison

BCAL vs SLDB Comparison

Compare BCAL & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern California Bancorp

BCAL

Southern California Bancorp

N/A

Current Price

$22.12

Market Cap

704.1M

Sector

Finance

ML Signal

N/A

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

N/A

Current Price

$7.17

Market Cap

623.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BCAL
SLDB
Founded
2001
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
704.1M
623.0M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
BCAL
SLDB
Price
$22.12
$7.17
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
★ $24.75
$18.71
AVG Volume (30 Days)
188.8K
★ 1.4M
Earning Date
10-28-2026
11-04-2026
Dividend Yield
★ 2.18%
N/A
EPS Growth
★ 777.27
34.97
EPS
★ 1.30
N/A
Revenue
N/A
★ $8,094,000.00
Revenue This Year
$1.29
N/A
Revenue Next Year
$6.46
N/A
P/E Ratio
$16.99
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$16.87
$4.16
52 Week High
$22.59
$11.45

Technical Indicators

Market Signals
Indicator
BCAL
SLDB
Relative Strength Index (RSI) 56.46 57.32
Support Level $20.68 $6.25
Resistance Level N/A $7.42
Average True Range (ATR) 0.53 0.47
MACD 0.03 0.19
Stochastic Oscillator 66.43 88.92

Price Performance

Historical Comparison
BCAL
SLDB

About BCAL Southern California Bancorp

California BanCorp is a relationship-focused community bank offering commercial loan and deposit products, along with other services delivered directly or through strategic alliances, to business and individual customers in its target markets. The Company provides financial products and services to individuals, professionals, and small to medium-sized businesses through its branch and commercial banking offices serving California. Its lending products consist mainly of construction and land development loans, real estate loans, C&I loans, and consumer loans, and it is a Preferred SBA Lender, while its deposit products consist mainly of demand deposit, money market, and certificates of deposit. The Company operates in one reportable segment, commercial banking.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: